Home > Journals > Chirurgia > Past Issues > Chirurgia 1999 August;12(4) > Chirurgia 1999 August;12(4):301-6

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

CHIRURGIA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index

 

ORIGINAL ARTICLES  


Chirurgia 1999 August;12(4):301-6

language: Italian

Chemotherapy (5-fluorouracil and folinic acid) in addition to surgical treatment of colorectal neoplasms

Longhini A., Landucci A., Borelli P., Kazemin A., Tessi W., Marcolli G.


PDF  


A retrospective study is made on the effects of chemotherapy on survival of patients with colorectal cancer who underwent resective surgery. The chemotherapeutic regimen was an association of 5-fluorouracil with folinic acid. In patients with stage II disease no benefit was derived by adding chemotherapy after operation, while survival was longer for patients with stage III-IV who received chemoterapy: the five-year survival rate for stage III was 62% for adjuvant chemotherapy versus 31% for surgery alone (p=0.99) and the two-year survival rate for stage IV was 33% for palliative chemotherapy versus 7% for surgery alone (p<0.001). All patients with node-positive (stage III) or metastatic (stage IV) colorectal cancer, should receive chemotherapy after operation, since it improves the results of therapy, as compared with surgery alone.

top of page

Publication History

Cite this article as

Corresponding author e-mail